Robbins Arroyo LLP: Antares Pharma, Inc. (ATRS) Misled Shareholders According to Class Action

SAN DIEGO & EWING, N.J.–(BUSINESS WIRE)–$ATRS #ClassAction–Shareholder rights law firm Robbins
Arroyo LLP
announces that purchasers of Antares Pharma, Inc.
(Nasdaq: ATRS) have filed a class action complaint against the company’s
officers and directors for alleged violations of the Securities Exchange
Act of 1934 between December 21, 2016 and October 12, 2017. Antares, a
specialty pharmaceutical company, develops pharmaceutical delivery

View this information on the law firm’s Shareholder Rights Blog: https://www.robbinsarroyo.com/antares-pharma-inc-nov-2018/

Antares New Drug Application Delayed Over Side Effects

According to the consolidated amended complaint filed on October 9,
2018, Antares announced its submission of a New Drug Application (“NDA”)
for Xyosted to the U.S. Food and Drug Administration (“FDA”) on December
21, 2016. Antares officials spoke optimistically about the drug’s
potential while downplaying adverse events involving suicide and high
blood pressure that occurred in Xyosted’s clinical trials. On October
12, 2017, Antares revealed that FDA had “identified deficiencies that
preclude the continuation of the discussion of labeling and post
marketing requirements/commitments” for Xyosted. On this news, Antares’
stock fell nearly 38% to close at $2.32 per share on October 13, 2017.
Days earlier, Antares’s Chairman of the Board, Leonard S. Jacob, sold
hundreds of thousands of shares of Antares stock, reaping a windfall of
nearly $1 million. On October 1, 2018, the company announced that the
FDA finally had approved the drug, but required a black box warning
describing risks of increased blood pressure and suicide.

Antares Shareholders Have Legal Options

Concerned shareholders who would like more information about their
rights and potential remedies can contact attorney Leonid Kandinov at
(800) 350-6003, LKandinov@robbinsarroyo.com,
or via the shareholder
information form
on the firm’s website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder
rights law. The firm represents individual and institutional investors
in shareholder derivative and securities class action lawsuits, and has
helped its clients realize more than $1 billion of value for themselves
and the companies in which they have invested. Sign up for our FREE
portfolio monitoring service, Stock

Attorney Advertising. Past results do not guarantee a similar outcome.


Robbins Arroyo LLP
Leonid Kandinov
525-3990 or Toll Free (800) 350-6003


I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.